1992
DOI: 10.1136/oem.49.11.761
|View full text |Cite
|
Sign up to set email alerts
|

Evaluation of exposure to polycyclic aromatic hydrocarbons in a coke production and a graphite electrode manufacturing plant: assessment of urinary excretion of 1-hydroxypyrene as a biological indicator of exposure.

Abstract: Objectives-Characterisation of the airborne concentration of 13 polycyclic aromatic hydrocarbons (PAHs) at various workplaces in a graphite electrode and a coke production plant. Validation of the urinary excretion of 1-hydroxypyrene (hydroxypyrene) as a biological marker of exposure to PAH.Design-Cross sectional study of workers exposed to PAHs (106 in the graphite electrode producing plant and 16 in the coke works).Methods-Personal air sampling during at least six hours per workshift using a glass fibre filt… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

7
64
1
3

Year Published

1993
1993
2016
2016

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 92 publications
(75 citation statements)
references
References 9 publications
7
64
1
3
Order By: Relevance
“…Several studies, predominantly focused on 1-PYR, have been conducted to estimate half-life (t 1/2 ) from various exposure routes. The t 1/2 after inhalation exposure has been determined to be 6.0-29 h. [12][13][14] For ingestion exposure, the 1-PYR t 1/2 was reported to be 4.4-12 h. [15][16][17] For dermal absorption, the 1-PYR t 1/2 was estimated at 11.5-15 h. 17,18 In several occupational studies on workers exposed through both inhalation and dermal absorption, the average t 1/2 ranged 10.4-18 h. [19][20][21] Increasingly, PAH biomonitoring studies are being carried out using multiple biomarkers in addition to 1-PYR. Some biomarkers or metabolic patterns have been proposed to be associated with specific sources or risk factors due to the change of enzyme polymorphism.…”
Section: Introductionmentioning
confidence: 99%
“…Several studies, predominantly focused on 1-PYR, have been conducted to estimate half-life (t 1/2 ) from various exposure routes. The t 1/2 after inhalation exposure has been determined to be 6.0-29 h. [12][13][14] For ingestion exposure, the 1-PYR t 1/2 was reported to be 4.4-12 h. [15][16][17] For dermal absorption, the 1-PYR t 1/2 was estimated at 11.5-15 h. 17,18 In several occupational studies on workers exposed through both inhalation and dermal absorption, the average t 1/2 ranged 10.4-18 h. [19][20][21] Increasingly, PAH biomonitoring studies are being carried out using multiple biomarkers in addition to 1-PYR. Some biomarkers or metabolic patterns have been proposed to be associated with specific sources or risk factors due to the change of enzyme polymorphism.…”
Section: Introductionmentioning
confidence: 99%
“…The urinary levels of 1-HP reflects the PAH exposure only during the last couple of days, due to the rather short half-life (18 h) of the metabolite (Buchet et al 1992). On the other hand, the occurrence of symptoms was asked for during 12 months.…”
Section: Discussionmentioning
confidence: 99%
“…creatinine) based on the regressions between the formation of an illness and the content of 1-OHP in urine, a higher lung carcinoma risk is estimated for the exposed workers in the carbon material production plant (18 (12).…”
Section: -Ohpmentioning
confidence: 99%